https://www.selleckchem.com/products/lw-6.html
34 ± 1.59, p 0.001) and motility improvement (with the mean RMDQ score dropping from 16.75 ± 1.84 to 7.21 ± 4.08, p 0.001). The motility improvement was significantly correlated with pain reduction (r = 0.42, p = 0.018), with the mean follow-up period being 19.3 ± 6.2 months (range 8-36 months). However, five patients who experienced moderate improvements had eventually received a revision operation after undergoing PPSV. The PPSV procedure is effective and safe for the reduction of pain and improvement of life quality in patient